From the company’s inception, GeneMind aimed at the research and development of the DNA sequencer: the core instrument of the modern molecular diagnostics. Genemind is committed to building a precision medical ecosystem that serves healthcare through collaborations with genetic testing service providers and medical institutions.
GeneMind has collaborated with QIAGEN to validate multiple mature NGS solutions from QIAGEN based on the GeneMind SURFSeq 5000* and GenoLab M* sequencing platforms. The test results demonstrate high compatibility between the GeneMind sequencing platforms and
Genetic sequencers in modern molecular diagnostics and research employ Next-generation Sequencing tests to decode DNA or RNA sequences. Hence, they enable precise genetic analysis for disease diagnosis, personalized medicine, and evolutionary
DNA sequencers in modern molecular diagnostics empower precise decoding of genetic material for understanding genetic disorders and developing targeted therapies. GeneMind Biosciences, or GeneMind, shines in these technologies and focuses
*Unless otherwise informed, GeneMind sequencing platform and related sequencing reagents are not available in the USA, Canada, Australia, Japan, Singapore, Western Europe and Nordic countries yet.
